ポリエチレングリコール製剤による慢性便秘症治療のストラテジー

出版社： 先端医学社
著者：
発行日： 2020-04-10
分野： 臨床医学：内科  >  胃/腸
ISBN： 9784865504552
電子書籍版： 2020-04-10 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

3,300 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,310 円(税込)

購入する

商品紹介

本書は慢性便秘症の定義や分類、発症機序にはじまり、診断の方法から治療についてエキスパートから詳細に解説されているまた治療においては数多くのエビデンスを有し、海外で便秘症治療の第一選択薬として用いられている、ポリエチレングリコール(PEG)製剤にフォーカスを当て、現在の慢性便秘症治のあり方からPEG製剤の有効性や安全性、さらには具体的な用い方について必要な情報を集約した。

目次

  • PART 1　慢性便秘症の定義と病態
    　1.わが国における慢性便秘症の現状 　
    　2.慢性便秘症の定義と分類

    PART 2　慢性便秘症治療の原因と病態生理
    　1.慢性便秘症の原因と病態
    　2.消化管運動と自律神経　
    　3.腸内細菌叢と便秘症との関連

    PART 3　慢性便秘症の診断と治療の考え方
    　1.慢性便秘症の診断手順と検査
    　2.慢性便秘症の臨床症状と鑑別診断
    　3.慢性便秘症治療の考え方と治療アルゴリズム

    PART 4　ポリエチレングリコール製剤の特徴と慢性便秘症治療における役割
    　1.ポリエチレングリコール製剤の薬理学的特徴と臨床薬理
    　2.各国における慢性便秘症の判断基準とガイドライン
    　3.小児における慢性便秘症のガイドラインとポリエチレングリコール製剤の位置づけ
    　4.ポリエチレングリコール製剤の副作用と安全性
    　5.ポリエチレングリコール製剤のQOLへの影響と服薬アドヒアランス
    　6.慢性便秘症における患者教育と排便習慣

    PART 5　ポリエチレングリコール製剤による慢性便秘症治療の実際
    　1.小児における慢性便秘症の診断と治療
    　2.成人における慢性便秘症の診断と治療
    　3.高齢者における便秘症の特徴と治療
    　4.女性における慢性便秘症とその治療
    　5.精神科における慢性便秘症とポリエチレングリコール製剤によるアプローチ
    　6.脳神経内科における便秘症とポリエチレングリコール製剤によるアプローチ
    　7.緩和医療における慢性便秘症とポリエチレングリコール製剤によるアプローチ
    　8.透析患者の慢性便秘症とポリエチレングリコール製剤によるアプローチ
    　9.クリニックにおける慢性便秘症とポリエチレングリコール製剤によるアプローチ
    　10.小児科の慢性便秘症における連携医療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

Part 1 慢性便秘症の定義と病態

P.17 掲載の参考文献
1) Locke GR 3rd, Pemberton JH, Phillips SF : American Gastroenterological Association Medical Position Statement : guidelines on constipation. Gastroenterology 119 : 1761-1766, 2000
PubMed
2) Talley NJ, Weaver AL, Zinsmeister AR et al : Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 136 : 165-177, 1992
PubMed
3) Choung RS, Locke GR 3rd, Schleck CD et al : Cumulative incidence of chronic constipation : a population-based study 1988-2003. Aliment Pharmacol Ther 26 : 1521-1528, 2007
PubMed
4) Suares NC, Ford AC : Prevalence of, and risk factors for, chronic idiopathic constipation in the community : systematic review and meta-analysis. Am J Gastroenterol 106 : 1582-1591, 2011
PubMed
5) Higgins PD, Johanson JF : Epidemiology of constipation in North America : a systematic review. Am J Gastroenterol 99 : 750-759, 2004
PubMed
6) Locke GR 3rd, Zinsmeister AR, Fett SL et al : Over-lap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 17 : 29-34, 2005
 
7) Chang JY, Locke GR 3rd, McNally MA et al : Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol 105 : 822-832, 2010
PubMed
8) Sumida K, Molnar MZ, Potukuchi PK et al : Constipation and risk of death and cardiovascular events. Atherosclerosis 281 : 114-120, 2019
PubMed
9) Choung RS, Rey E, Richard Locke G 3rd et al : Chronic constipation and co-morbidities : a prospective population-based nested case-control study. United European Gestroenterol J 4 : 142-151, 2016
PubMed
10) Salmoirago-Blotcher E, Crawford S, Jackson E et al : Constipation and risk of cardiovascular disease among Postmenopausal women. Am J Med 124 : 714-723, 2011
PubMed
11) Honkura K, Tomata Y, Sugiyama K et al : Defecation frequency and cardiovascular disease mortality in Japan : The Ohsaki cohort study. Atherosclerosis 246 : 251-256, 2016
PubMed
12) Ishiyama Y, Hoshide S, Mizuno H et al : Constipation-induced pressor effects as triggers for cardiovascular events. J Clin Hypertens (Greenwich) 21 : 421-425, 2019
PubMed
13) Hara K, Hirowatari Y, Yoshika M et al : The ratio of plasma to whole-blood serotonin may be a novel marker of atherosclerotic cardiovascular disease. J Lab Clin Med 144 : 31-37, 2004
PubMed
14) Costedio MM, Coates MD, Brooks EM et al : Mucosal serotonin signaling is altered in chronic constipation but not in opiate-induced constipation. Am J Gastroenterol 105 : 1173-1180, 2010
 
15) Pstras L, Thomaseth K, Waniewski J et al : The Valsalva manoeuvre : physiology and clinical examples. Acta Physiol (Oxf) 217 : 103-119, 2016
PubMed
16) Mulak A, Bonaz B : Brain-gut-microbiota axis in Parkinson's disease. World J Gastroenterol 21 : 10609-10620, 2015
PubMed
17) Almeida MN, Silvernale C, Kuo B et al : Bowel symptoms predate the diagnosis among many patients with multiple sclerosis : a 14-year cohort study. Neurogastroenterol Motil 31 : e13592, 2019
PubMed
18) Gilsenan A, Fortuny J, Cainzos-Achirica M et al : Cardiovascular safety of prucalopride in patients with chronic constipation : a multinational population-based cohort study. Drug Saf 42 : 1179-1190, 2019
 
P.23 掲載の参考文献
1) 慢性便秘症診療ガイドライン 2017, 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京, 2017
 
2) Bharucha AE, Pemberton JH, Locke GR 3rd : American Gastroenterological Association technical review on constipation. Gastroenterology 144 : 218-238, 2013
PubMed
3) Ford AC, Moayyedi P, Lacy BE et al : American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 109 (Suppl 1) : S2-S26, 2014
 
4) Lacy BE, Mearin F, Chang L et al : Bowel disorders Gastroenterology 150 : 1393-1407, 2016
 
5) 松橋信行 : 2-11 便秘. 内科学第9版, 杉本恒明, 矢崎義雄編, 朝倉書店, 東京, 2007, pp80-81
 
6) Lembo A, Camilleri M : Chronic constipation. N Engl J Med 349 : 1360-1368, 2003
PubMed

Part 2 慢性便秘症の原因と病態生理

P.29 掲載の参考文献
1) 第1章 2. 慢性便秘 (症) の分類. 慢性便秘症診療ガイドライン 2017, 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京, 2017, pp3-5
 
2) Andrews CN, Storr M : The pathophysiology of chronic constipation. Can J Gastroenterol 25 (Suppl B) : 16B-21B, 2011
 
3) Bharucha AE : Pelvic floor : anatomy and function. Neurogastroenterol Motil 18 : 507-519, 2006
PubMed
4) Dinning PG. Smith TK. Scott SM : Pathophysiology of colonic causes of chronic constipation. Neurogastroenterol Motil 21 (Suppl 2) : 20-30, 2009
 
5) Wedel T, Spiegler J, Soellner S et al : Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology 123 : 1459-1467, 2002
PubMed
6) Bassotti G, Villanacci V : Slow transit constipation : a functional disorder becomes an enteric neuropathy. World J Gastroenterol 12 : 4609-4613, 2006
PubMed
7) Bassotti G, Villanacci V, Nascimbeni R et al : Colonic mast cells in controls and slow transit constipation patients. Aliment Pharmacol Ther 34 : 92-99, 2011
PubMed
8) Chan OT, Chiles L, Levy M et al : Smoothelin expression in the gastrointestinal tract : implication in colonic inertia. Appl Immunohistochem Mol Morphol 21 : 452-459, 2013
PubMed
9) Wedel T, Van Eys GJ, Waltregny D et al : Novel smooth muscle markers reveal abnormalities of the intestinal musculature in severe colorectal motility disorders. Neurogastroenterol Motil 18 : 526-538, 2006
PubMed
10) Tzavella K, Riepl RL, Klauser AG et al : Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol 8 : 1207-1211, 1996
PubMed
11) Sjolund K, Fasth S, Ekman R et al : Neuropeptides in idiopathic chronic constipation (slow trarlsit constipation). Neurogastroenterol Motil 9 : 143-150, 1997
PubMed
12) Faussone-Pellegrini MS, Infantino A, Matini P et al : Neuronal anomalies and normal muscle morphology at the hypomotile ileocecocolonic region of patients affected by idiopathic chronic constipation. Histol Histopathol 14 : 1119-1132, 1999
PubMed
13) Kobayashi A, Yokota H, Kobayashi H et al : Mucosal neuroendocrine cell abnormalities in patients with chronic constipation. Asian J Surg 27 : 197-201, 2004
PubMed
14) Ghoshal UC, Sachdeva S, Pratap N et al : Indian consensus on chronic constipation in adults : a joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology. Indian J Gastroenterol 37 : 526-544, 2018
PubMed
15) Bassotti G, Villanacci V : Can "functional" constipation be considered as a form of enteric neuro-gliopathy? Glia 59 : 345-350, 2011
PubMed
16) Chatterjee S, Park S, Low K et al : The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol 102 : 837-841, 2007
PubMed
17) Black CJ, Ford AC : Chronic idiopathic constipation in adults : epidemiology, pathophysiology, diagnosis and clinical management. Med J Aust 209 : 86-91, 2018
PubMed
18) Rao SS : Dyssynergic defecation and biofeedback therapy. Gastroenterol Clin North Am 37 : 569-586, 2008
PubMed
P.33 掲載の参考文献
1) Furness JB, Callaghan BP, Rivera LR et al : The enteric nervous system and gastrointestinal innervation : integrated local and central control. Adv Exp Med Biol 817 : 39-71, 2014
PubMed
2) Furness JB : The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 9 : 286-294, 2012
PubMed
3) Goldstein AM, Hofstra RM, Burns AJ : Building a brain in the gut : development of the enteric nervous system. Clin Genet 83 : 307-316, 2013
PubMed
4) Schemann M : Control of gastrointestinal motility by the "gut brain" -the enteric nervous system. J Pediatr Gastroenterol Nutr 41 (Suppl 1) : S4-S6, 2005
 
5) Schemann M, Neunlist M : The human enteric nervous system. Neurogastroenterol Motil 16 (Suppl 1) : 55-59, 2004
 
6) Furness JB : Integrated neural and endocrine control of gastrointestinal function. Adv Exp Med Biol 891 : 159-173, 2016
PubMed
7) Tsigos C, Chrousos GP : Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53 : 865-871, 2002
PubMed
8) de Groat WC. Nadelhaft I, Milne RJ et al : Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst 3 : 135-160, 1981
 
9) Howland RH : Vagus nerve stimulation. Curr Behav Neurosci Rep 1 : 64-73, 2014
PubMed
10) Nerves and Nerve Injuries Vol 1 : History, Embryology, Anatomy, Imaging, and Diagnostics, ed by Tubbs RS, Rizk E. Shoja MM et al, Academic Press, Cambridge, 2015
 
11) Altschuler SM, Escardo J, Lynn RB et al : The central organization of the vagus nerve innervating the colon of the rat. Gastroenterology 104 : 502-509, 1993
PubMed
12) Bessant AR, Robertson-Rintoul J : Origin of the parasympathetic preganglionic fibers to the distal colon of the rabbit as demonstrated by the horseradish peroxidase method. Neurosci Lett 63 : 17-22, 1986
 
13) Caulfield MP, Birdsall NJ : International Union of Pharmacology. XVII. classification of muscarinic acetylcholine receptors. Pharmacol Rev 50 : 279-290, 1998
PubMed
14) Stephens GJ, Mochida S : Gprotein βγ subunits mediate presynaptic inhibition of transmitter release from rat superior cervical ganglion neurones in culture. J Physiol 563 : 765-776, 2005
 
15) Tanaka Y, Horinouchi T, Koike K : New insights into beta-adrenoceptors in smooth muscle : distribution of receptor subtypes and molecular mechanisms triggering muscle relaxation. Clin Exp Pharmacol Physiol 32 : 503-514, 2005
PubMed
16) Uchiyama T, Chess-Williams R : Muscarinic receptor subtypes of the bladder and gastrointestinal tract. J Smooth Muscle Res 40 : 237-247, 2004
PubMed
17) Grasa L, Rebollar E, Arruebo MP et al : The role of Ca2+ in the contractility of rabbit small intestine in vitro. J Physiol Pharmacol 55 : 639-650, 2004
PubMed
18) Evans ED, Mangel AW : Depolarization-stimulated contractility of gastrointestinal smooth muscle in calcium free solution : a review. ISRN Gastroenterol 2011 : 692528, 2011
PubMed
19) Hansen MB : Neurohumoral control of gastrointestinal motility. Physiol Res 52 : 1-30, 2003
PubMed
20) Camborova P, Hubka P, Sulkova I et al : The pacemaker activity of interstitial cells of Cajal and gastric electrical activity. Physiol Res 52 : 275-284, 2003
PubMed
P.37 掲載の参考文献
1) 内藤裕二, 高木智久, 井上亮 : 慢性便秘症と腸内細菌学. 日本消化器病学会雑誌 115 : 940-949, 2018
Medical*Online
2) 高木智久, 井上亮, 柏木里織ほか : 日本人健常成人における便性状からみた腸内細菌叢. 機能性食品と薬理栄養 12 : 54-59, 2018
 
3) Heaton KW, Radvan J, Cripps H et al : Defecation frequency and timing, and stool form in the general population : a prospective study. Gut 33 : 818-824, 1992
PubMed
4) Degen LP, Phillips SF : How well does stool form reflect colonic transit? Gut 39 : 109-113, 1996
PubMed
5) Longstreth GF, Thompson WG, Chey WD et al : Functional bowel disorders. Gastroenterology 130 : 1480-1491, 2006
PubMed
6) 慢性便秘症診療ガイドライン 2017. 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京, 2017
 
7) Vandeputte D, Falony G, Vieira-Silva S et al : Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65 : 57-62, 2016
PubMed
8) Nishijima S, Suda W, Oshima K et al : The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res 23 : 125-133, 2016
PubMed
9) Takagi T, Naito Y, Inoue R et al : Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol 54 : 53-63, 2019
PubMed
10) Nishino K, Nishida A, Inoue R et al : Analvsis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. J Gastroenterol 53 : 95-106, 2018
 
11) Kashiwagi S, Naito Y, Inoue R et al : Mucosa-associated microbiota in the gastrointestinal tract of healthy Japanese subjects. Digestion 5 : 1-14, 2019
 
12) Parthasarathy G, Chen J, Chen X et al : Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology 150 : 367-379, 2016
 
13) Keely S, Kelly CJ, Weissmueller T et al : Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiome. Gut Microbes 3 : 250-260, 2012
PubMed
14) Kato T, Honda Y, Kurita Y et al : Lubiprostone improves intestinal permeabnity in humans, a novel therapy for the leaky gut : a prospective randomized pilot study in healthy volunteers. PLoS One 12 : e0175626, 2017
 
15) Ge X, Zhao W, Ding C et al : Potential role of fecal microbiota from patients with slow transit constipation in the regulation of gastrointestinal motility. Sci Rep 7 : 441, 2017
PubMed
16) Tian H, Ge X, Nie Y et al : Fecal microbiota transplantation in patients with slow-transit constipation : a randomized, clinical trial. PLoS One 12 : e0171308, 2017
PubMed
17) Mizuno S, Masaoka T, Naganuma M et al : Bifidobacterium-rich fecal donor may be a positive predictor for successful fecal microbiota transplantation in patients with irritable bowel syndrome. Digestion 96 : 29-38, 2017
PubMed
18) Inoue R, Sakaue Y, Kawada Y et al : Dietary supplementation with partially hydrolyzed guar gum helps improve constipation and gut dysbiosis symptoms and behavioral irritability in children with autism spectrum disorder. J Clin Biochem Nutr 64 : 217-223, 2019
PubMed

Part 3 慢性便秘症の診断と治療の考え方 - わが国のガイドラインを中心に -

P.43 掲載の参考文献
1) 慢性便秘症診療ガイドライン 2017, 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京. 2017
 
2) Heaton KW, Ghosh S, Braddon FE : How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? a prospective, controlled study with emphasis on stool form. Gut 32 : 73-79, 1991
PubMed
3) Thompson WM : Gasless abdomen in the adult : what does it mean? AJR Am J Roentgenol 191 : 1093-1099, 2008
PubMed
4) Walker NI, Bennett RE, Axelsen RA : Melanosis coli. a consequence of anthraquinone-induced apoptosis of colonic epithelial cells. Am J Pathol 131 : 465-476, 1988
 
5) Mizukami T, Sugimoto S, Masaoka T et al : Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome. Intest Res 25 : 236-243, 2017
 
6) 藪中幸一, 松尾淳子, 原明子ほか : 超音波画像による大腸内に貯留した便とガスの比較検討. 超音波検査技術 38 : 605-613, 2013
Medical*Online
7) Manabe N, Kamada T, Hata J et al : New ultrasonographic evaluation of stool and/or gas distribution for treatment of chronic constipation. Int J Colorectal Dis 33 : 345-348, 2018
PubMed
8) Ohgo H, Imaeda H, Yamaoka M et al : Irritable bowel syndrome evaluation using computed tomography colonography. World J Gastroenterol 22 : 9394-9399, 2016
PubMed
P.48 掲載の参考文献
1) Lembo A, Camilleri M : Chronic constipation. N Engl J Med 349 : 1360-1368, 2003
PubMed
2) Wong RK, Palsson OS, Turner MJ et al : Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol 105 : 2228-2234, 2010
PubMed
P.53 掲載の参考文献
1) 厚生労働省 : 日本人の食事摂取基準 (2015年版) の概要 https://www.mhlw.go.jp/file/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka/0000041955.pdf
 
2) 高齢者の安全な薬物療法ガイドライン 2015, 日本老年医学会, 日本医療研究開発機構研究費・高齢者の薬物治療の安全性に関する研究研究班, メジカルビュー社, 東京, 2015
 
3) Wakai E, Ikemura K, Sugimoto H et al : Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide : a retrospective cohort study. J Pharm Health Care Sci 5 : 4, 2019
PubMed
4) Ohkubo H, Yoshihara T, Misawa N et al : Relationship between stool form and quality of life in patients with chronic constipation : an internet questionnaire survey. Digestion 1 : 1-8, 2019
PubMed

Part 4 ポリエチレングリコール製剤の特徴と慢性便秘症治療における役割

P.59 掲載の参考文献
1) Davis GR, Santa Ana CA, Morawski SG et al : Development of a lavage solution associated with minimal water and electrolyte absorption or secretion. Gastroenterolgy 78 : 991-995, 1980
PubMed
2) DiPalma JA, Brady CE 3rd, Stewart DL et al : Comparison of colon cleansing methods in preparation for colonoscopy. Gastroenterology 86 : 856-860, 1984
PubMed
3) 上野文昭, 荒川正一, 岩村健一郎ほか : 特殊組成電解質液服用による大腸内視鏡前処置法. 日本消化器内視鏡学会雑誌 29 : 509-515, 1987
 
4) Fortran JS, Santa Ana CA, Cleveland MvB : A low-sodium solution for gastrointestinal lavage. Gastroenterology 98 : 11-16, 1990
 
5) Andorsky RI, Goldner F : Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation : a double-blind placebo-controlled study. Am J Gastroenterol 85 : 261-265, 1990
PubMed
6) Corazziari E, Badiali D, Brazzochi G et al : Long term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF 100) in the treatment of functional chronic constipation. Gut 46 : 522-526, 2000
PubMed
7) Dipalma JA, Cleveland MV, McGowan J et al : A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol 102 : 1436-1441, 2007
 
8) Brandt LJ, Prather CM, Quigley EM et al : Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 100 : S5-S21, 2005
PubMed
9) American Gastroenterological Association, Bharucha AE, Dorn SD et al : American Gastroenterological Association medical position statement on constipation. Gastroenterology 144 : 211-217, 2013
PubMed
10) Lindberg G, Hamid SS, Malfertheiner P et al : World Gastroenterology Organisation global guidehne : constipation-a global perspective.J Clin Gastroenterol 45 : 483-487, 2011
PubMed
11) Lee-Robichaud H, Thomas K, Morgan J et al : Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev 7 : CD007570, 2010
 
P.62 掲載の参考文献
1) Jun DW, Park HY, Lee OY et al : A population-based study on bowel habits in a Korean community : prevalence of functional constipation and self-reported constipation. Dig Dis Sci 51 : 1471-1477, 2006
 
2) Rajput M, Saini SK : Prevalence of constipation among the general population : a community-based survey from India. Gastroenterol Nurs 37 : 425-429, 2014
PubMed
3) Pare P, Ferrazzi S, Thompson WG et al : An epidemiological survey of constipation in Canada : definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 96 : 3130-3137, 2001
PubMed
4) Adibi P, Behzad E, Pirzadeh S et al : Bowel habit reference values and abnormalities in young Iranian healthy adults. Dig Dis Sci 52 : 1810-1813, 2007
PubMed
5) Peppas G, Alexiou VG, Mourtzoukou E et al : Epidemiology of constipation in Europe and Oceania : a systematic review. BMC Gastroenterol 8 : 5, 2008
PubMed
6) Higgins PD, Johanson JF : Epidemiology of constipation in North America : a systematic review. Am J Gastroenterol 99 : 750-759, 2004
PubMed
7) Cheng C, Chan AO, Hui WM et al : Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation : a population-based study. Aliment Pharmacol Ther 18 : 319-326, 2003
PubMed
8) Chu H, Zhong L, Li H et al : Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in China. Gastroenterol Res Pract 532734, 2014
 
9) Mearin, F, Lacy BE, Chang L et al : Bowel disorders. Gastroenterology 150 : 1393-1407, 2016
 
10) Ford AC, Moayyedi P, Lacy BE et al : American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 109 (Suppl 1) : S2-S26, 2014
 
11) 慢性便秘症診療ガイドライン 2017, 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京, 2017, p6
 
12) National Institute for Health and Care Excellence : Constipation in children and young people : diagnosis and management, 2010, pp17-22
 
13) Tabbers MM, Dilorenzo C, Berger MY et al : Evaluation and treatment of functional constipation in infants and children : evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 58 : 258-274, 2014
PubMed
14) 小児慢性機能性便秘症診療ガイドライン, 日本小児栄養消化器肝臓学会, 日本小児消化管機能研究会編, 診断と治療社, 東京, 2013
 
15) Bharucha AE, Pemberton JH, Locke GR 3rd : American Gastroenterological Association technical review on constipation. Gastroenterology 144 : 218-238, 2013
PubMed
16) American College of Gastroenterology Chronic Constipation Task Force : An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 100 : S1-S4, 2005
 
17) Lindberg G, Hamid SS, Malfertheiner P et al : World Gastroenterology Organisation global guideline : constipation-a global perspective. J Clin Gastroenterol 45 : 483-487, 2011
PubMed
18) Wald A : Constipation : advances in diagnosis and treatment. JAMA 315 : 185-191, 2016
PubMed
P.67 掲載の参考文献
1) Mugie SM Benninga MA, Di Lorenzo C : Epidemiology of constipation in children and adults : a systematic review. Best Pract Res Clin Gastroenterol 25 : 3-18, 2011
PubMed
2) Walter H, Hovenkamp A, Rajindrajith S et al : OP-12 prevalence of functional constipation in infants and toddlers in Sri Lanka. J Pediatr Gastroenterol Nutr 61 : 541, 2015
 
3) Bhatia V, Deswal S, Seth S et al : Prevalence of functional gastrointestinal disorders among adolescents in Delhi based on Rome III criteria : a school-based survey. Indian J Gastroenterol 35 : 294-298, 2016
PubMed
4) Baker SS, Liptak GS, Colletti RB et al : Constipation in infants and children : evaluation and treatment. a medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 29 : 612-626, 1999
PubMed
5) 小児慢性機能性便秘症診療ガイドライン, 日本小児栄養消化器肝臓学会, 日本小児消化管機能研究会編, 診断と治療社, 東京, 2013 http://www.jspghan.org/constipation/index.html
 
6) Tabbers MM, DiLorenzo C, Berger MY et al : Evaluation and treatment of functional constipation in infants and children : evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 58 : 258-274, 2014 http://www.naspghan.org/files/documents/pdfs/cme/jpgn/Evaluation_and_Treatment_of_Functional.24.pdf
 
7) Constipation in children and young People : diagnosis and management of idiopathic childhood constipation in primary and secondary care. http://www.nice.org.uk/guidance/cg99/evidence/fuil-guidance-245466253
 
8) Loening-Baucke V : Prevalence, symptoms and out-come of constipation in infants and toddlers. J Pedial 146 : 359-363, 2005
 
9) Borowitz SM, Cox DJ, Sutphen JL et al : Treatment of childhood encopresis : a randomized trial comparing three treatment protocols. J Pediatr Gastroenterol Nutr 34 : 378-384, 2002
PubMed
10) Gorrindo P, Williams KC, Lee EB et al : Gastrointestinal dysfunction in autism : parental report, clinical evaluation, and associated factors. Autism Res 5 : 101-108, 2012
PubMed
11) McKeown C, Hisle-Gorman E, Eide M et al : Association of constipation and fecal incontinence with attention-deficit/hyperactivity disorder. Pediatrics 132 : e1210-e1215, 2013
PubMed
12) Benninga MA, Faure C, Hyman PE et al : Childhood functional gastrointestinal disorders : neonate/toddler. Gastroenterology 150 : 1443-1455, 2016
 
13) Hyams JS. Di Lorenzo C. Saps M et al : Childhood functional gastrointestinal disorders : child/adolescent. Gastroenterology 150 : 1456-1468, 2016
 
14) Alper A, Pashankar DS : Polyethylene glycol : a game-changer laxative for children. J Pediatr Gastroenterol Nutr 57 : 134-140, 2013
 
15) Gordon M, Naidoo K, Akobeng AK et al : Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev 7 : CD009118, 2012
PubMed
16) Savino F, Viola S, Erasmo M et al : Efficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children, a controlled double blind randomized study vs a standard peg-electrolyte laxative. BMC Pediatr 12 : 178, 2012
 
P.72 掲載の参考文献
1) 慢性便秘症診療ガイドライン 2017, 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京, 2017, p66
 
2) 小児慢性機能性便秘症診療ガイドライン, 日本小児栄養消化器肝臓学会, 日本小児消化管機能研究会編, 診断と治療社, 東京, 2013, p58
 
3) モビコール(R) 配合内用剤, 医薬品インタビューフォーム
 
4) モビコール(R) のclinical study (小児) https://www.eapharma.co.jp/medicalexpert/product/movicol/clinicalchild/safety.html
 
5) 医薬用医薬品 : モビコール https://www.kegg.jp/medicus-bin/japic_med?japic_code=00067759
 
6) Voskuijl W, de Lorjin F, Verwijs W et al : PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation : a double blind, randomised, controlled, multicentre trial. Gut 53 : 1590-1594, 2004
 
7) Loening-Baucke V, Pashankar DS : A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk magnesia for children with constipation and fecal incontinence. Pediatrics 118 : 528-535, 2006
PubMed
8) Dupont C, Leluyer B, Maamri N : Double-blind randomized evaluation of clinical and biologcal tolerance of polyethylene glycol 4000 versus lactulose in constipated chiidren. J Pediatr Gastroenterol Nutr 41 : 625-633, 2005
 
9) Terry NA, Chen-Lim ML, Ely E et al : Polyethylene glycol powder solution versus senna for bowel preparation for colonoscopy in children. J Pediatr Gastroenterol Nutr 56 : 215-219, 2013
 
10) Chassagne P, Ducrotte P, Garnier P et al : Tolerance and long-term efficacy of polyethylene glycol 4000 (FORLAX(R)) compared to iactulose in elderly patients with chronic constipation. J Nutr Health Aging 21 : 429-439, 2017
 
11) Minguez M, Lopez Higueras A, Judez J : Use of polyethylene glycol in functional constipation and fecal impaction. Rev Esp Enferm Dig 108 : 790-806, 2016
PubMed
12) 小児慢性機能性便秘症診療ガイドライン, 日本小児栄養消化器肝臓学会, 日本小児消化管機能研究会編, 診断と治療社, 東京, 2013, p57
 
P.76 掲載の参考文献
1) 厚生労働省 : 平成28年度国民生活基礎調査
 
2) 慢性便秘症診療ガイドライン 2017, 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京, 2017
 
3) Krogh K, Chiarioni G, Whitehead W : Management of chronic constipation in adults. United European Gastroenterol J 5 : 465-472, 2017
PubMed
4) 坪井謙之介, 寺町ひとみ, 葛谷有美ほか : 服薬アドヒアランスに影響を及ぼす患者の意識調査. 医療薬学 38 : 522-533, 2012
Medical*Online
P.79 掲載の参考文献
1) 鳥居明 : 過敏性腸症候群. 医学のあゆみ 46 : 14-24, 2000
 
2) Dukas L, Willett WC, Giovannucci EL : Association between physical activity, fiber intake, and other life-style variables and constipation in a study of women. Am J Gastroenterol 98 : 1790-1796, 2003
 

Part 5 ポリエチレングリコール製剤による慢性便秘症治療の実際

P.85 掲載の参考文献
1) 厚生労働省 : 平成27年度乳幼児栄養調査結果の概要 https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000134208.html
 
2) 清水俊明 : 便秘. 小児科診療ガイドライン-最新の治療指針- <第4版>, 五十嵐隆編. 総合医学社, 東京, 2019, pp11-15
 
3) 小児慢性機能性便秘症診療ガイドライン, 日本小児栄養消化器肝臓学会, 日本小児消化管機能研究会編, 診断と治療社, 東京, 2013, pp1-67
 
4) 清水俊明, 幾瀬圭 : 便秘症, 小児科臨床 71 : 767-772, 2018
Medical*Online
P.94 掲載の参考文献
1) 第1章 定義・分類・診断基準. 慢性便秘症診療ガイドライン 2017, 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京, 2017, pp1-7
 
2) 味村俊樹 : 定義・分類・診断基準. 臨牀消化器内科 33 : 367-375, 2018
 
3) 味村俊樹 : II-5 慢性便秘. 消化器疾患最新の治療 2019-2020, 小池和彦, 山本博徳, 瀬戸泰之編, 南江堂, 東京, 2019, pp86-91
 
4) 味村俊樹 : 便秘の病態・診断の基本. レジデント 11 : 6-17, 2017
 
5) 味村俊樹, 本間祐子, 堀江久永 : 慢性便秘症の機能検査. 消化器・肝臓内科 5 : 163-173, 2019
 
6) 味村俊樹 : 慢性便秘症の初期診療. 診断と治療 106 : 811-819, 2018
Medical*Online
7) 味村俊樹 : 慢性便秘症治療薬の正しい使い方 新生児便秘症治療薬の適切な使用方法をマスターする. レジデントノート 21 : 715-723, 2019
 
8) Minguez M, Lopez HA, Judez J : Use of polyethylene glycol in functional constipation and fecal impaction. Rev Esp Enferm Dig 108 : 790-806, 2016
 
9) Nakajima A, Shinbo K, Oota A et al : Polyethylene glycol 3350 plus electrolytes for chronic constipation : a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension. J Gastroenterol : 54 : 792-803, 2019
PubMed
10) Attar A, Lemann M, Ferguson A et al : Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 44 : 226-230, 1999
PubMed
11) Bouhnik Y, Neut C, Raskine L et al : Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. Aliment Pharmacol Ther 19 : 889-899, 2004
 
12) Lee-Robichaud H, Thomas K, Morgan J et al : Lactulose versus polyethylene glycol for chronic constipation, Cochrane Database Syst Rev 7 : CD007570, 2010
 
13) 味村俊樹 : 高齢者の排便障害の特徴と治療. 臨床老年看護 25 : 2-13, 2018
 
14) Culbert P, Gillett H, Ferguson A : Highly effective new oral therapy for faecal impaction. Br J Gen Pract 48 : 1599-1600, 1998
PubMed
15) Chen CC, Su MY, Tung SY et al : Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults. Curr Med Res Opin 21 : 1595-1602, 2005
PubMed
16) 味村俊樹, 本間祐子, 堀江久永 : 慢性便秘症の外科治療. 日本消化器病学会雑誌 115 : 967-976, 2018
Medical*Online
17) 味村俊樹 : 便排出障害 (直腸肛門機能障害). 診断と治療 101 : 285-290, 2013
Medical*Online
18) 味村俊樹 : 機能性便排出障害型便秘症に対するバイオフィードバック療法の実際. 臨床医のための慢性便秘マネジメントの必須知識, 中島淳編, 医薬ジャーナル社, 大阪, 2015, pp176-182
 
19) 味村俊樹, 本間祐子, 堀江久永 : 排便障害に対する仙骨神経刺激療法とバイオフィードバックによるリハビリテーション. 外科 81 : 506-516, 2019
 
20) 味村俊樹 : 直腸瘤の診断と治療. 臨床外科 63 : 339-349, 2008
 
P.98 掲載の参考文献
1) 厚生労働省 : 平成28年度国民生活基礎調査
 
2) 厚生労働省 : 高齢者の医薬品適正使用の指針 (総論編)
Medical*Online
3) Talley NJ, Jones M, Nuyts G et al : Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol 98 : 1107-1111, 2003
PubMed
4) Fox C, Richardson K, Maidment ID et al : Anticholinergic medication use and cognitive impairment in the older population : the medical research council cognitive function and ageing study. J Am Geriatr Soc 59 : 1477-1483, 2011
PubMed
5) Rao S, Lembo AJ, Shiff SJ et al : A 12-week, randomized, controlled trial with a 4-week randomized with drawl period to evaluate the efficacy and safety of linaclotide in irritable bowed syndrome with constipation. Am J Gastroenterol 107 : 1714-1724, 2012
 
6) 高齢者の安全な薬物療法ガイドライン 2015, 日本老年医学会編, メジカルビュー社, 東京, 2015
 
7) Emmanuel A, Mattace-Raso F, Neri MC et al : Constipation in older people : a consensus statement. Int J Clin Pract 71 : 2017
 
P.102 掲載の参考文献
1) Prather CM : Pregnancy-related constipation. Curr Gastroenterolo Rep 6 : 402-404, 2004
 
2) 北岡有喜 : 妊娠に伴うマイナートラブルへの対応 便秘-妊娠中の便秘の科学. ペリネイタルケア 19 : 988-992, 2000
 
3) Marti, Roche, Delをaval et al : Rectoceles : value of videodefecography in selection of treatment policy. Colorectal Dis 1 : 324-329, 1999
 
4) Jewell D, Young G : Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev CD001142, 2011
 
5) 厚生労働省 : 平成27年国民健康・栄養調査報告の結果 https://www.mhlw.go.jp/file/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka/0000041955.pdf
 
6) 中野かおる, 高橋知子, 角田明良ほか : V章. 排泄障害に対するリハビリテーション 12. 食事指導. リハスタッフのための排泄リハビリテーション実践アプローチ, 鈴木重行, 井上倫恵編, メジカルビュー社, 東京, 2018, pp336-345
 
7) Yamana T, Takahashi T, Iwadare J et al : Clinical and physiologic outcomes after transvaginal rectocele repair. Dis Colon Rectum 49 : 661-667, 2006
PubMed
8) 藤井渉, 角田明良, 高橋知子 : 直腸瘤に対するtransanal anterior Delorme法の治療成績. 日本大腸肛門病学会雑誌 69 : 66-74, 2016
 
P.106 掲載の参考文献
1) Kim B, Susan M, Scott Bほか : ギャノング生理学 (原書 25版), 岡田泰伸監修, 丸善出版, 東京, 2017, pp306-310
 
2) 認知症テキストブック, 日本認知症学会編, 中外医学社, 東京, 2008, p39
 
3) Fujishiro H, Iseki E, Nakamura S et al : Dementia with Lewy bodies : early diagnostic challenges. Psychogeriatrics 213 : 128-138, 2013
 
P.111 掲載の参考文献
1) 榊原隆次 : 多系統萎縮症 vs パーキンソン病 自律神経症候から見た鑑別法 消化管障害 (解説). 自律神経 53 : 218-221, 2016
 
2) Sakakibara R, Kishi M, Ogawa E et al : Bladder, bowel, and sexual dysfunction in Parkinson's disease. Parkinsons Dis 2011 : 924605, 2011
PubMed
3) Sakakibara R, Doi H, Fukudo S : Lewy body constipation. J Anus Rectum Colon 3 : 10-17, 2019
PubMed
4) Recasens A, Dehay B : Alpha-synuclein spreading in Parkinson's disease. Front Neuroanat 8 : 159, 2014
PubMed
5) Doi H, Sakakibara R, Masuda M et al : Gastrointestinal function in dementia with Lewy bodies : a comparison with Parkinson disease. Clin Auton Res 29 : 633-638, 2019
PubMed
6) Sakakibara R, Tateno F, Aiba Y et al : MIBG myocardial scintigraphy identifies premotor PD/DLB during anegative DAT scan period : second report. Mov Disord Clin Pract 6 : 46-50, 2018
 
7) Arai E, Arai M, Uchiyama T et al : Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain 135 : 1478-1485, 2012
PubMed
8) Tateno H, Sakakibara R, Shiina S et al : Transdermal dopamine agonist ameliorates gastric emptying in Parkinson's disease. J Am Geriatr Soc 63 : 2416-2418, 2015
PubMed
9) 神経・精神疾患による消化管障害ベッドサイドマニュアル, 榊原隆次, 福土審編著, 中外医学社, 東京, 2019
 
10) Sakakibara R, Yamaguchi T, Uchiyama T : Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects. Mov Disord 22 : 1672-1673, 2007
PubMed
11) Eichhorn TE, Oertel WH : Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy. Mov Disord 16 : 1176-1177, 2001
PubMed
12) Zangaglia R, Martignoni E, Glorioso M et al : Macrogol for the treatment of constipation in Parkinson's disease. a randomized placebo-controlled study. Mov Disord 22 : 1239-1244, 2007
PubMed
P.115 掲載の参考文献
1) 慢性便秘症診療ガイドライン 2017, 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京, 2017
 
2) がん患者の消化器症状の緩和に関するガイドライン 2017年版, 日本緩和医療学会ガイドライン統括委員会編, 金原出版, 東京, 2017
 
3) 平山功 : 緩和医療における便秘治療の重要性と実際の治療. Pharma Medica 35 : 39-43, 2017
Medical*Online
4) Larkin PJ, Cherny NI, La Carpia D et al : Diagnosis, assessment and managelnent of constipation in advanced cancer : ESMO Clinical Practice Guidelines. Ann Oncol 29 (Suppl 4) : iv111-iv125, 2018
 
5) McQuade RM, Stojanovska V, Abalo R et al : Chemotherapy-induced constipation and diarrhea : pathophysiology, current and emerging treatments. Front Pharmacol 7 : 414, 2016
PubMed
6) Brock C, Olesen SS, Olesen AE et al : Opioid-induced bowel dysfunction : pathophysiology and management. Drugs 72 : 1847-1865, 2012
PubMed
7) Ishihara M Ikesue H, Matsunaga H et al : A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. Clin J Pain 28 : 373-381, 2012
PubMed
8) Larkin PJ, Sykes NP, Centeno C et al : The management of constipation in palliative care : clinical practice recommendations. Palliat Med 22 : 796-807, 2008
PubMed
9) 厚生労働省医薬・生活衛生局 : 医薬品医療機器等安全性情報 No. 328, 2015
 
10) Wirz S, Klaschik E : Management of constipation in palliative care patients undergoing opioid therapy : is polyethylene glycol an option? Am J Hosp Palliat Care 22 : 375-381, 2005
PubMed
11) Lee-Robichaud H, Thomas K, Morgan J et al : Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev 7 : CD007570, 2010
 
12) Chen CC, Su MY, Tung SY et al : Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults. Curr Med Res Opin 21 : 1595-1602, 2005
PubMed
13) 中島淳, 冬木晶子, 稲生優海ほか : 便秘治療薬の動向. Pharma Medica 35 : 31-34, 2017
Medical*Online
14) Freedman MD, Schwartz HJ, Roby R et al : Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation : a double-blinded placebo-controlled trial. J Clin Pharmacol 37 : 904-907, 1997
 
15) Wirz S, Nadstawek J, Elsen C et al : Laxative management in ambulatory cancer patients on opioid therapy : a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose. Eur J Cancer Care 21 : 131-140, 2012
 
P.121 掲載の参考文献
1) 中島淳 : 慢性便秘の病態. 診断と治療 101 : 211-216, 2013
Medical*Online
2) Yasuda G, Shibata K, Takizawa T et al : Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients. Am J Kidney Dis 39 : 1292-1299, 2002
PubMed
3) 西原舞, 平田純生, 和泉智ほか : 透析患者の便秘症についての実態調査. 日本透析医学会雑誌 37 : 1887-1892, 2004
 
4) 福岡県腎臓病患者連絡協議会 : 便秘アンケート調査結果, ふくじんきょう 259 : 2-7, 2016
 
5) 西原舞, 平田純生, 山川智之 : 透析患者における便秘と虚血性腸炎. 大阪透析研究会会誌 23 : 55-59, 2005
Medical*Online
6) 飯田倫理, 酒巻裕一, 山本卓ほか : 慢性の便秘症とメタボリック症候群から大腸イレウス・腹部コンパートメント症候群に陥った慢性腎不全の1例. 臨牀透析 31 : 471-474, 2015
 
7) 中村忠博, 松永典子, 樋口則英ほか : 酸化マグネシウム製剤の腎機能低下患者における血清マグネシウム値への影響. 日本腎臓病薬物療法学会誌 2 : 3-9, 2013
Medical*Online
8) 平田純生, 和泉智, 古久保拓ほか : Sevelamer hydrochloride投与による便秘症予防のための下剤使用法の検討. 日本透析医学会雑誌 37 : 1967-1973, 2004
 
9) Christie J, Shroff S. Shahnavaz N et al : A randomized, double-blind, placebo-controlled trial to examine the effectiveness of lubiprostone on constipation symptoms and colon transit time in diabetic patients. Am J Gastroenterol 112 : 356-364, 2017
PubMed
10) 吉田拓弥, 古久保拓, 田中千春ほか : 血液透析患者の便秘症に対するルビプロストンの臨床効果. 大阪透析研究会会誌 32 : 29-32, 2014
Medical*Online
11) 元志宏, 野辺香奈子, 金井弘次ほか : ルビプロストン投与により大腸メラノーシスが改善した維持透析患者の1例. 日本透析医学会雑誌 50 : 163-166, 2017
 
P.127 掲載の参考文献
1) 岡崎啓介 : 放射線不透過マーカーを用いた大腸通過時間の測定-便秘の質的診断のために-. 日本大腸肛門病学会雑誌 63 : 339-345, 2010
 
2) 岡崎啓介 : 刺激性下剤の使い方の検討-大腸通過時間を指標として-. 日本大腸肛門病学会雑誌 64 : 408-413, 2011
 
3) 慢性便秘症診療ガイドライン 2017, 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会編, 南江堂, 東京, 2017
 
4) 岡崎啓介, 山田春樹, 森永紀 : 大黄・センナ含有医薬品のセンノシドA・B定量による刺激性下剤成分の評価. 兵庫県医師会医学雑誌 59 : 32-36, 2017
 
5) Honkura K, Tomata Y, Sugiyama K et al : Defecation frequency and cardiovascular disease mortality in Japan : The Ohsaki cohort study. Atherosclerosis 246 : 251-256, 2016
PubMed
6) 味村俊樹 : 慢性便秘症の初期診療. 診断と治療 106 : 811-819, 2018
Medical*Online
7) 大腸肛門機能障害研究会HP https://kinoushougai.wixsite.com/mysite/blank-4
 
8) 国立健康・栄養研HP. 「健康食品」の素材情報データベース https://hfnet.nibiohn.go.jp/contents/indiv.html
 
9) 岡崎啓介, 森永紀 : 刺激性下剤強度ランキング表2019の作成. 日本臨床肛門病学会雑誌 3 : 81-86, 2019
 
P.130 掲載の参考文献
1) 小児慢性機能性便秘症診療ガイドライン, 日本小児栄養消化器肝臓学会, 日本小児消化管機能研究会編, 診断と治療社, 東京, 2013, p30
 
2) 小児慢性機能性便秘症診療ガイドライン, 日本小児栄養消化器肝臓学会, 日本小児消化管機能研究会編, 診断と治療社, 東京, 2013, p33
 
3) Nakajima A, Shinbo K, Oota A et al : Polyethylene glycol 3350 plus electrolytes for chronic constipation : a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension. J Gastroenterol 54 : 792-803, 2019
PubMed
P.133 掲載の参考文献
1) 菊地有紀, 薬袋淳子, 島内節 : 在宅重度要介護高齢者の排泄介護における家族介護者の負担に関連する要因. 国際医療福祉大学紀要 15 : 13-23, 2010
 
2) 中島淳, 冬木晶子, 稲生優海ほか : 便秘治療薬の動向. Pharma Medica 35 : 31-34, 2017
Medical*Online

書評

最近チェックした商品履歴

Loading...